HealthCap

All figures cover the European funds tracked here since 1 January 2025, whether closed or still raising, and are compiled from public sources.

Tracked funds

1

Reported volume

€48m

Latest public closing

22 Aug 2025

Reported volume sums the public fund amounts tracked here, not the manager's firm-wide assets under management, so it may differ from totals on the manager's website.

Life-sciences venture capital firm and company creator based in Stockholm.

Focus: Precision medicine and emerging therapies for significant unmet medical needs, including rare diseases, cancer and genetic diseases

August 2025: HealthCap IX reached final close above its target; fund size not publicly disclosed (trade press).